Parvoviruses-tools to fine-tune anticancer immune responses

Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection

(2012) S P Grekova et al.   CANCER GENE THERAPY

Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent

(2011) Svitlana P. Grekova et al.   CANCER BIOLOGY & THERAPY

Oncolytic parvoviruses as cancer therapeutics

(2010) Jean Rommelaere et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Enhancement of NK cell antitumor responses using an oncolytic parvovirus

(2010) Rauf Bhat et al.   INTERNATIONAL JOURNAL OF CANCER

Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

(2009) A. L. Angelova et al.   CLINICAL CANCER RESEARCH

Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity

(2008) Zahari Raykov et al.   INTERNATIONAL JOURNAL OF CANCER